Sage Therapeutics, Inc. Research and Development Expense
Sage Therapeutics, Inc. reported Research and Development Expense of $23.92 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-07-30
- Sage Therapeutics, Inc. research and development expense for the quarter ending 2025-06-30 was $23.92M, a 61.77% decline year-over-year.
- Sage Therapeutics, Inc. research and development expense for the quarter ending 2025-03-31 was $22.76M, a 68.27% decline year-over-year.
- Sage Therapeutics, Inc. research and development expense for the quarter ending 2024-12-31 was $37.02M, a 42.45% decline year-over-year.
- Sage Therapeutics, Inc. research and development expense for the quarter ending 2024-09-30 was $54.58M, a 46.45% decline year-over-year.
- Sage Therapeutics, Inc. research and development expense for fiscal 2024 was $225.90M, a 36.59% decline from fiscal 2023.
- Sage Therapeutics, Inc. research and development expense for fiscal 2023 was $356.24M, a 9.22% increase from fiscal 2022.
- Sage Therapeutics, Inc. research and development expense for fiscal 2022 was $326.16M, a 15.18% increase from fiscal 2021.
- Sage Therapeutics, Inc. research and development expense for fiscal 2021 was $283.17M, a 3.26% decline from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $23.92M 10-Q · filed 2025-07-30 | $46.68M 10-Q · filed 2025-07-30 | $83.70M derived: sum of 3 quarters · filed 2025-07-30 | $138.27M derived: sum of 4 quarters · filed 2025-07-30 |
| 2025-03-31 | $22.76M 10-Q · filed 2025-04-29 | $59.78M derived: sum of 2 quarters · filed 2025-04-29 | $114.36M derived: sum of 3 quarters · filed 2025-04-29 | $176.92M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-12-31 | $37.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $91.60M derived: sum of 2 quarters · filed 2025-02-11 | $154.16M derived: sum of 3 quarters · filed 2025-07-30 | $225.90M 10-K · filed 2025-02-11 |
| 2024-09-30 | $54.58M 10-Q · filed 2024-10-29 | $117.14M derived: sum of 2 quarters · filed 2025-07-30 | $188.87M 10-Q · filed 2024-10-29 | $253.20M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-06-30 | $62.56M 10-Q · filed 2025-07-30 | $134.30M 10-Q · filed 2025-07-30 | $198.63M derived: sum of 3 quarters · filed 2025-07-30 | $300.55M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | $71.73M 10-Q · filed 2025-04-29 | $136.06M derived: sum of 2 quarters · filed 2025-04-29 | $237.98M derived: sum of 3 quarters · filed 2025-04-29 | $335.14M derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $64.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $166.25M derived: sum of 2 quarters · filed 2025-02-11 | $263.41M derived: sum of 3 quarters · filed 2025-02-11 | $356.24M 10-K · filed 2025-02-11 |
| 2023-09-30 | $101.92M 10-Q · filed 2024-10-29 | $199.08M derived: sum of 2 quarters · filed 2024-10-29 | $291.90M 10-Q · filed 2024-10-29 | $381.20M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $97.16M 10-Q · filed 2024-07-31 | $189.99M 10-Q · filed 2024-07-31 | $279.28M derived: sum of 3 quarters · filed 2025-02-11 | $360.83M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $92.83M 10-Q · filed 2024-04-25 | $182.12M derived: sum of 2 quarters · filed 2025-02-11 | $263.67M derived: sum of 3 quarters · filed 2025-02-11 | $340.97M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $89.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $170.85M derived: sum of 2 quarters · filed 2025-02-11 | $248.15M derived: sum of 3 quarters · filed 2025-02-11 | $326.16M 10-K · filed 2025-02-11 |
| 2022-09-30 | $81.55M 10-Q · filed 2023-11-07 | $158.85M derived: sum of 2 quarters · filed 2023-11-07 | $236.87M 10-Q · filed 2023-11-07 | $312.31M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $77.30M 10-Q · filed 2023-08-07 | $155.31M 10-Q · filed 2023-08-07 | $230.76M derived: sum of 3 quarters · filed 2024-02-14 | $314.25M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $78.02M 10-Q · filed 2023-05-02 | $153.46M derived: sum of 2 quarters · filed 2024-02-14 | $236.96M derived: sum of 3 quarters · filed 2024-02-14 | $303.13M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $75.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $158.94M derived: sum of 2 quarters · filed 2024-02-14 | $225.11M derived: sum of 3 quarters · filed 2024-02-14 | $283.17M 10-K · filed 2024-02-14 |
| 2021-09-30 | $83.50M 10-Q · filed 2022-11-08 | $149.67M derived: sum of 2 quarters · filed 2022-11-08 | $207.72M 10-Q · filed 2022-11-08 | $289.43M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $66.17M 10-Q · filed 2022-08-02 | $124.23M 10-Q · filed 2022-08-02 | $205.93M derived: sum of 3 quarters · filed 2023-02-16 | $280.01M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $58.06M 10-Q · filed 2022-05-03 | $139.76M derived: sum of 2 quarters · filed 2023-02-16 | $213.84M derived: sum of 3 quarters · filed 2023-02-16 | $287.16M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $81.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $155.78M derived: sum of 2 quarters · filed 2023-02-16 | $229.10M derived: sum of 3 quarters · filed 2023-02-16 | $292.71M 10-K · filed 2023-02-16 |
| 2020-09-30 | $74.08M 10-Q · filed 2021-11-02 | $147.40M derived: sum of 2 quarters · filed 2021-11-02 | $211.01M 10-Q · filed 2021-11-02 | $302.26M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $73.32M 10-Q · filed 2021-08-03 | $136.93M 10-Q · filed 2021-08-03 | $228.18M derived: sum of 3 quarters · filed 2022-02-24 | $330.29M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $63.61M 10-Q · filed 2021-05-04 | $154.86M derived: sum of 2 quarters · filed 2022-02-24 | $256.97M derived: sum of 3 quarters · filed 2022-02-24 | $346.03M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $91.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $193.36M derived: sum of 2 quarters · filed 2022-02-24 | $282.42M derived: sum of 3 quarters · filed 2022-02-24 | $368.81M 10-K · filed 2022-02-24 |
| 2019-09-30 | $102.11M 10-Q · filed 2020-11-05 | $191.17M derived: sum of 2 quarters · filed 2020-11-05 | $277.56M 10-Q · filed 2020-11-05 | $366.37M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $89.06M 10-Q · filed 2020-08-10 | $175.46M 10-Q · filed 2020-08-10 | $264.26M derived: sum of 3 quarters · filed 2021-02-24 | $339.31M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $86.40M 10-Q · filed 2020-05-07 | $175.20M derived: sum of 2 quarters · filed 2021-02-24 | $250.25M derived: sum of 3 quarters · filed 2021-02-24 | $319.24M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $88.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $163.86M derived: sum of 2 quarters · filed 2021-02-24 | $232.84M derived: sum of 3 quarters · filed 2021-02-24 | $282.11M 10-K · filed 2021-02-24 |
| 2018-09-30 | $75.05M 10-Q · filed 2019-11-12 | $144.03M derived: sum of 2 quarters · filed 2019-11-12 | $193.30M 10-Q · filed 2019-11-12 | $244.19M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $68.98M 10-Q · filed 2019-08-06 | $118.25M 10-Q · filed 2019-08-06 | $169.14M derived: sum of 3 quarters · filed 2020-02-27 | $227.43M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $49.27M 10-Q · filed 2019-05-02 | $100.16M derived: sum of 2 quarters · filed 2020-02-27 | $158.45M derived: sum of 3 quarters · filed 2020-02-27 | $214.35M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $50.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $109.18M derived: sum of 2 quarters · filed 2020-02-27 | $165.08M derived: sum of 3 quarters · filed 2020-02-27 | $210.28M 10-K · filed 2020-02-27 |
| 2017-09-30 | $58.29M 10-Q · filed 2018-11-06 | $114.19M derived: sum of 2 quarters · filed 2018-11-06 | $159.39M 10-Q · filed 2018-11-06 | $201.39M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $55.90M 10-Q · filed 2018-08-07 | $101.10M 10-Q · filed 2018-08-07 | $143.10M derived: sum of 3 quarters · filed 2019-02-19 | $172.18M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $45.20M 10-Q · filed 2018-05-03 | $87.20M derived: sum of 2 quarters · filed 2019-02-19 | $116.28M derived: sum of 3 quarters · filed 2019-02-19 | $142.38M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $71.08M derived: sum of 2 quarters · filed 2019-02-19 | $97.17M derived: sum of 3 quarters · filed 2019-02-19 | $120.76M 10-K · filed 2019-02-19 |
| 2016-09-30 | $29.07M 10-Q · filed 2017-11-02 | $55.17M derived: sum of 2 quarters · filed 2017-11-02 | $78.75M 10-Q · filed 2017-11-02 | $99.13M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $26.10M 10-Q · filed 2017-08-03 | $49.68M 10-Q · filed 2017-08-03 | $70.05M derived: sum of 3 quarters · filed 2018-02-22 | $87.53M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $23.58M 10-Q · filed 2017-05-10 | $43.96M derived: sum of 2 quarters · filed 2018-02-22 | $61.44M derived: sum of 3 quarters · filed 2018-02-22 | $80.04M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $20.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $37.85M derived: sum of 2 quarters · filed 2018-02-22 | $56.46M derived: sum of 3 quarters · filed 2018-02-22 | $69.36M 10-K · filed 2018-02-22 |
| 2015-09-30 | $17.48M 10-Q · filed 2016-11-03 | $36.08M derived: sum of 2 quarters · filed 2016-11-03 | $48.98M 10-Q · filed 2016-11-03 | $57.93M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $18.60M 10-Q · filed 2016-08-09 | $31.50M 10-Q · filed 2016-08-09 | $40.45M derived: sum of 3 quarters · filed 2017-02-24 | $47.05M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $12.90M 10-Q · filed 2016-05-06 | $21.84M derived: sum of 2 quarters · filed 2017-02-24 | $28.45M derived: sum of 3 quarters · filed 2017-02-24 | $32.83M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $15.55M derived: sum of 2 quarters · filed 2017-02-24 | $19.93M derived: sum of 3 quarters · filed 2017-02-24 | $24.10M 10-K · filed 2017-02-24 |
| 2014-09-30 | $6.60M 10-Q · filed 2015-11-06 | $10.98M derived: sum of 2 quarters · filed 2015-11-06 | $15.15M 10-Q · filed 2015-11-06 | $19.67M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $4.38M 10-Q · filed 2015-08-12 | $8.55M 10-Q · filed 2015-08-12 | $13.07M derived: sum of 3 quarters · filed 2016-02-29 | $16.47M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $4.17M 10-Q · filed 2015-05-15 | $8.69M derived: sum of 2 quarters · filed 2016-02-29 | $12.09M derived: sum of 3 quarters · filed 2016-02-29 | $15.95M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $7.92M derived: sum of 2 quarters · filed 2016-02-29 | $11.77M derived: sum of 3 quarters · filed 2016-02-29 | $14.36M 10-K · filed 2016-02-29 |
| 2013-09-30 | $3.41M 10-Q · filed 2014-11-13 | $7.26M derived: sum of 2 quarters · filed 2014-11-13 | $9.85M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $3.85M 10-Q · filed 2014-08-14 | $6.44M 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | $7.23M 10-K · filed 2015-03-06 |